As depression and gastroesophageal reflux disease often occur together and many of SSRI (selective serotonin reuptake inhibitors) demonstrate some extent of CYP inhibitory properties, it is important to determine whether potentially harmful interactions occur between antidepressants and cisapride. This evidence concerns the gene PPIG and gastroesophageal reflux disease.